Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension (TRUST-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00494533
Recruitment Status : Terminated (Safety issues related to outpatient intravenous infusion in India)
First Posted : June 29, 2007
Last Update Posted : January 29, 2014
Asian Clinical Trials
Information provided by (Responsible Party):
United Therapeutics